The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis

European Radiology

Volumn 26, Issue 8, 2016, Pages 2670-2684

  Wang, Qun ^a   Zhang, Hui ^b   Zhang, JiaShu ^a   Wu, Chen ^a   Zhu, WeiJie ^c   Li, FangYe ^a   Chen, XiaoLei ^a   Xu, BaiNan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Differentiation; Glioma; Magnetic resonance spectroscopy; Meta analysis; Systematic review

Indexed keywords

LACTIC ACID; LIPID; ASPARTIC ACID; CHOLINE; CREATINE; N-ACETYLASPARTATE;

AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GLIOMA; HISTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; BRAIN TUMOR; DIAGNOSTIC IMAGING; FACTUAL DATABASE; META ANALYSIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

AREA UNDER CURVE; ASPARTIC ACID; BRAIN NEOPLASMS; CHOLINE; CREATINE; DATABASES, FACTUAL; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM GRADING; ROC CURVE;

EID: 84944561172     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-4046-z     Document Type: Article

References (55)

1. Inoue T, Ogasawara K, Beppu T, Ogawa A, Kabasawa H (2005) Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg 107:174–180
2. Lu H, Pollack E, Young R et al (2008) Predicting grade of cerebral glioma using vascular-space occupancy MR imaging. AJNR Am J Neuroradiol 29:373–378
3. Chung C, Metser U, Menard C (2015) Advances in magnetic resonance imaging and positron emission tomography imaging for grading and molecular characterization of glioma. Semin Radiat Oncol 25:164–171
4. Bulik M, Jancalek R, Vanicek J, Skoch A, Mechl M (2013) Potential of MR spectroscopy for assessment of glioma grading. Clin Neurol Neurosurg 115:146–153
5. Herminghaus S, Dierks T, Pilatus U et al (2003) Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 98:74–81
6. Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol 9:906–920
7. Zhang H, Ma L, Wang Q, Zheng X, Wu C, Xu BN (2014) Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis. Eur J Radiol 83:2181–2189
8. Hollingworth W, Medina LS, Lenkinski RE et al (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 27:1404–1411
9. Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536
10. Deville WL, Buntinx F, Bouter LM et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9
11. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
13. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM (2008) Systematic reviews of diagnostic test accuracy. Ann Intern Med 149:889–897
14. Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219
15. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893
16. Fudaba H, Shimomura T, Abe T et al (2014) Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading. AJNR Am J Neuroradiol 35:2091–2098
17. Dunet V, Maeder P, Nicod-Lalonde M et al (2014) Combination of MRI and dynamic FET PET for initial glioma grading. Nuklearmedizin 53:155–161
18. Caulo M, Panara V, Tortora D et al (2014) Data-driven grading of brain gliomas: a multiparametric MR imaging study. Radiology 272:494–503
19. Darweesh AMN, Badawy ME, Hamesa M, Saber N (2014) Magnetic resonance spectroscopy and diffusion imaging in the evaluation of neoplastic brain lesions. Egypt J Radiol Nucl Med 45:485–493
20. Yoon JH, Kim JH, Kang WJ et al (2014) Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy. Eur Radiol 24:380–389
21. Metwally LIA, El-Din SE, Abdelaziz O, Hamdy IM, Elsamman AK, Abdelalim AM (2014) Predicting grade of cerebral gliomas using Myo-inositol/Creatine ratio. Egypt J Radiol Nucl Med 45:211–217
22. Sahin N, Melhem ER, Wang S et al (2013) Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade. Neuroradiol J 26:531–541
23. Roy B, Gupta RK, Maudsley AA et al (2013) Utility of multiparametric 3-T MRI for glioma characterization. Neuroradiology 55:603–613
24. Rao PJ, Jyoti R, Mews PJ, Desmond P, Khurana VG (2013) Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas. Br J Neurosurg 27:646–653
25. Chawalparit O, Sangruchi T, Witthiwej T et al (2013) Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service. J Med Assoc Thai 96:1365–1373
26. Aprile I, Torni C, Fiaschini P, Muti M (2012) High-Grade Cerebral Glioma Characterization: Usefulness of MR Spectroscopy and Perfusion Imaging Associated Evaluation. Neuroradiol J 25:57–66
27. Shokry A (2012) MRS of brain tumors: diagrammatic representations and diagnostic approach. Egypt J Radiol Nucl Med 43:603–612
28. Liu ZL, Zhou Q, Zeng QS, Li CF, Zhang K (2012) Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy. J Int Med Res 40:76–84
29. Zou QG, Xu HB, Liu F, Guo W, Kong XC, Wu Y (2011) In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Clin Radiol 66:953–960
30. Zeng Q, Liu H, Zhang K, Li C, Zhou G (2011) Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy. Magn Reson Imaging 29:25–31
31. 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement. J Neurol Neurosurg Psychiatry 82:512–520
32. Chernov MF, Ono Y, Muragaki Y et al (2008) Differentiation of high-grade and low-grade gliomas using pattern analysis of long-echo single-voxel proton magnetic resonance spectroscopy ((1)H-MRS). Neuroradiol J 21:338–349
33. Di CA, Scarabino T, Trojsi F et al (2008) Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent. Eur Radiol 18:1727–1735
34. Zonari P, Baraldi P, Crisi G (2007) Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 49:795–803
35. 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2. Neuroradiology 49:913–919
36. 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. AJNR Am J Neuroradiol 27:1412–1418
37. Stadlbauer A, Gruber S, Nimsky C et al (2006) Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238:958–969
38. 1H MR spectroscopy. Clin Imaging 29:10–15
39. Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W (2005) Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12:51–57
40. Chen CY, Lirng JF, Chan WP, Fang CL (2004) Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. J Formos Med Assoc 103:448–458
41. Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS, Gotsis ED (2004) Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 82:90–97
42. Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998
43. Kumar A, Kaushik S, Tripathi RP, Kaur P, Khushu S (2003) Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience. Neurol India 51:474–478
44. Yang D, Korogi Y, Sugahara T et al (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44:656–666
45. 1H-chemical shift imaging method. NMR Biomed 10:25–30
46. Wang W, Hu Y, Lu P et al (2014) Evaluation of the diagnostic performance of magnetic resonance spectroscopy in brain tumors: a systematic review and meta-analysis. PLoS One 9, e112577
47. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56:1129–1135
48. Server A, Kulle B, Gadmar OB, Josefsen R, Kumar T, Nakstad PH (2011) Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol 80:462–470
49. 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology 48:312–318
50. Moller-Hartmann W, Herminghaus S, Krings T et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381
51. Bertholdo D, Watcharakorn A, Castillo M (2013) Brain proton magnetic resonance spectroscopy: introduction and overview. Neuroimaging Clin N Am 23:359–380
52. 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232
53. Pamir MN, Ozduman K, Yildiz E, Sav A, Dincer A (2013) Intraoperative magnetic resonance spectroscopy for identification of residual tumor during low-grade glioma surgery: clinical article. J Neurosurg 118:1191–1198
54. Bradac O, Vrana J, Jiru F et al (2014) Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy. Br J Neurosurg 28:631–636
55. Hattingen E, Raab P, Franz K et al (2008) Prognostic value of choline and creatine in WHO grade II gliomas. Neuroradiology 50:759–767